Stock Track | Moderna Plummets 7.67% Intraday on Bearish Analyst Rating and Profit-Taking Pressure

Stock Track
07/10

Moderna, Inc. (MRNA) saw its stock price plummet 7.67% during intraday trading, extending a multi-session pullback from recent highs.

The decline comes as Bank of America maintained its underperform rating on the stock with a target price of $38, representing a discount of more than 50% to the current share price. The bank also flagged that Moderna's upcoming second-quarter earnings release could face heightened market scrutiny, adding to investor concerns.

Market participants have largely priced in recent positive catalysts, including the FDA committee's unanimous support for Moderna's seasonal flu vaccine candidate. The combination of institutional bearishness and sustained profit-taking pressure following the stock's previous sharp rally continues to weigh on Moderna's shares.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10